03 January 2025 : Review article
Skeletal Muscle Relaxants and Their Impact on Intracranial Pressure in Neurosurgery
Łukasz Grabarczyk

DOI: 10.12659/MSM.946569
Med Sci Monit 2025; 31:e946569
Table 1 Summary of main effects of different neuromuscular blocking agents (NBMA) of the revised clinical studies. Studies are assigned to specific NBMAs and presented in reverse chronological order. For each study, the first author, year of publication, number of patients studied, NMBA used, most relevant cerebrovascular effects, and corresponding reference are provided.
Drug group | NMBA | Cerebrovascular effects | First Author, year | Reference | Patients (n) | Control group |
---|---|---|---|---|---|---|
Depolarizing agent | Succinylcholine | ICP does not change | Kovarik, 1994 | []20 | 10 | Same patient |
ICP increased | Stirt, 1987 | []21 | 12 | Two groups | ||
ICP increased | Minton, 1986 | []19 | 13 | Same patient | ||
Benzylisoquinolines | Atracurium | ICP, CPP, CBFV, and MAP decreased | Schramm, 1998 | []30 | 14 | Same patient |
Control of otherwise unstable ICP | McClelland, 1995 | []29 | 4 | Same patient | ||
No changes in ICP, CPP, or MAP | Unni, 1986 | []27 | 9 | Same patient | ||
No changes in ICP, MAP, CVP, HR, and etCO2 | Rosa, 1986 | []26 | 25 | Same patient | ||
No changes in ICP, CPP, or MAP | Minton, 1985 | []25 | 20 | Two groups | ||
Cisatracurium | Prevention of increase in ICP | Chivite Fernández, 2005 | []48 | 13 | Same patient | |
No changes in ICP, CPP, CBFV, and MAP | Schramm 1998 | []30 | 14 | Same patient | ||
No changes in ICP, CPP, CBFV, MAP, and HR regardless of dose | Schramm, 1997 | []31 | 24 | Two groups | ||
Mivacurium | No changes in ICP, CSFP or MAP | Cafiero, 1999 | []35 | 12 | Same patient | |
Aminosteroids | Pancuronium | ICP decreased, elevated HR and arterial pressure | Thiel, 1996 | []41 | 10 | Two groups |
Pipecuronium | ICP decreased, stable HR and arterial pressure | Thiel, 1996 | []41 | 10 | Two groups | |
No changes in ICP, MAP, CVP, HR, and etCO2 | Di Giugno, 1992 | []49 | 10 | Same patient | ||
Rocuronium | No significant changes in ICP, MAP, CPP. Treatment caused slight increase in HR | Schramm, 1996 | []47 | 20 | Two groups | |
Vecuronium | ICP increased | Kerwin 2000 | []50 | 23 | Same patient | |
Treatment caused no significant changes in ICP, CPP, or MAP | Schramm, 1996 | []47 | 20 | Two groups | ||
ICP slightly decreased | Rosa, 1986 | []43 | 20 | Same patient | ||
ICP – intracranial pressure; CPP – cerebral perfusion pressure; CBFV – cerebral blood flow velocity; MAP – mean arterial pressure; CVP – central venous pressure; HR – heart rate; etCO2 – end-tidal CO2; CSFP – cerebrospinal fluid pressure. |